Genmab to Participate in a Fireside Chat at the 2025 Jefferies Global Health Care Conference

Company Overview - Genmab A/S is an international biotechnology company focused on improving the lives of patients through innovative antibody therapeutics [2][3] - Established in 1999 and headquartered in Copenhagen, Denmark, Genmab has a global presence across North America, Europe, and Asia Pacific [3] Product Pipeline and Vision - Genmab has developed a proprietary pipeline that includes bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function-enhanced antibodies [2] - The company's vision by 2030 is to transform the lives of people with cancer and other serious diseases through groundbreaking antibody medicines, referred to as "knock-your-socks-off" (KYSO) therapies [2] Upcoming Events - Judith Klimovsky, Chief Development Officer of Genmab, will participate in a fireside chat at the 2025 Jefferies Global Health Care Conference on June 5, 2025, at 9:20 EDT [1]